Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Lee Jennifer Kayden. Officer active across 1 company, notably Rhythm Pharmaceuticals, INC.. Cumulatively, 20 reports have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €8.7m. History available since 7 August 2023. The latest transaction was filed on 13 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lee Jennifer Kayden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
35,000 shares@ US$24.290.011% mcap7.4% of flowCommon StockSEC:0001649904-26-000009:0
21,601 shares@ US$6.800.0018% mcap1.3% of flowCommon StockSEC:0001649904-26-000009:1
75,834 shares@ US$117.38180.11% mcap77.8% of flowCommon StockSEC:0001649904-26-000009:2
22,612 sharesCommon StockSEC:0001104659-26-009767:0
5,500 sharesCommon StockSEC:0001104659-25-015320:0
600 shares@ US$56.392.4% of flowCommon StockSEC:0001104659-25-014257:0
3,437 sharesCommon StockSEC:0001104659-25-011677:0
1,733 shares@ US$60.08117.5% of flowCommon StockSEC:0001104659-25-010610:0
4,513 sharesCommon StockSEC:0001104659-25-009284:0
20,622 shares@ US$6.809.8% of flowCommon StockSEC:0001104659-24-117942:0
9,169 shares@ US$38.2224.1% of flowCommon StockSEC:0001104659-24-037880:0
15,515 shares@ US$39.2241.7% of flowCommon StockSEC:0001104659-24-036312:0
33,750 shares0Common StockSEC:0001104659-24-026154:0
3,438 sharesCommon StockSEC:0001104659-24-022538:0
4,513 sharesCommon StockSEC:0001104659-24-010800:0
12,030 shares@ US$6.805.7% of flowCommon StockSEC:0001104659-23-119095:0
5,712 shares@ US$6.802.7% of flowCommon StockSEC:0001104659-23-117365:0
80 shares@ US$6.800.0% of flowCommon StockSEC:0001104659-23-115368:0
4,519 shares@ US$6.802.1% of flowCommon StockSEC:0001104659-23-099017:0
8,591 shares@ US$6.804.0% of flowCommon StockSEC:0001104659-23-089331:0
About Lee Jennifer Kayden
Lee Jennifer Kayden is a declarant linked to Rhythm Pharmaceuticals, INC., where she holds the role of EVP, Head of North America. The record shows 17 filings in total, and across the 17 sampled filings between 2023-08-09 and 2026-02-03, sales total 1015204 EUR, with Levée d'options as the most frequent transaction nature.